Blood pharmacokinetic sample collection, processing and transport in COVID-19 clinical trials

This procedure describes the process for taking pharmacokinetic (PK) samples from the phlebotomist to processing in an interim processing (e.g. ward) laboratory and onto an analytical laboratory in clinical trials.

This guidance document has been adapted from the WWARN Clinical Trials Toolkit for COVID-19 clinical trials. Author: WWARN